Hamburg Calls for Greater Trust, Transparency Among International Regulators
The FDA and international regulators must establish a much more collaborative framework in order to ensure the safety of the world’s drug supply chains, FDA Commissioner Margaret Hamburg says.
“If I can look at a set of inspections from [the European Medicines Agency (EMA)] or Health Canada for my decisions, we’ll all benefit,” Hamburg said in a panel discussion with EMA executive director Guido Rasi and Health Canada’s assistant deputy minister Paul Glover at the 2012 Drug Information Association’s annual meeting Monday.
Countries do not need to have the same standards and checklists to achieve the same results, but they need to ensure the integrity and comparability of outcomes, Hamburg said. And in order to depend on different countries’ regulators, minimum standards need to be established.
Are you a drugmaker with supplier contracts across the globe? Are you aware of the collaboration between international regulators regarding inspections into manufacturing practices and supplier management?
Get three days and two nights of face-to-face interchange with top regulators and policymakers, industry experts, lawyers and consultants discussing hat actions are being taken to strengthen the international supply chain.
This congress is the opportunity you’ve been looking for. Make sure you reserve yourself a spot and we’ll see you there.
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!